AllovirInc Stock Performance

ALVR Stock  USD 6.01  0.23  3.98%   
The firm shows a Beta (market volatility) of 2.6502, which signifies a somewhat significant risk relative to the market. Let's try to break down what AllovirInc's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AllovirInc will likely underperform. Even though it is essential to pay attention to AllovirInc historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. AllovirInc exposes twenty-one different technical indicators, which can help you to evaluate its performance. AllovirInc has an expected return of -0.15%. Please be advised to confirm AllovirInc downside deviation, treynor ratio, as well as the relationship between the Treynor Ratio and expected short fall to decide if AllovirInc performance from the past will be repeated at some point in the near future.
  
AllovirInc Performance
0 of 100
Over the last 90 days AllovirInc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more

AllovirInc Price Channel

Begin Period Cash Flow122.7 M
Total Cashflows From Investing Activities186 M

AllovirInc Relative Risk vs. Return Landscape

If you would invest  709.00  in AllovirInc on November 4, 2022 and sell it today you would lose (108.00)  from holding AllovirInc or give up 15.23% of portfolio value over 90 days. AllovirInc is currently does not generate positive expected returns and assumes 4.9844% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than AllovirInc, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days AllovirInc is expected to under-perform the market. In addition to that, the company is 4.51 times more volatile than its market benchmark. It trades about -0.03 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.14 per unit of volatility.

AllovirInc Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for AllovirInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AllovirInc, and traders can use it to determine the average amount a AllovirInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.03

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsALVR
Estimated Market Risk
 4.98
  actual daily
 
 43 %
of total potential
 
4343
Expected Return
 -0.15
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.03
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average AllovirInc is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AllovirInc by adding it to a well-diversified portfolio.

About AllovirInc Performance

To evaluate AllovirInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when AllovirInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare AllovirInc Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand AllovirInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents AllovirInc's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.

Things to note about AllovirInc

Checking the ongoing alerts about AllovirInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AllovirInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Please continue to Trending Equities. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for analysis

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
546.9 M
Return On Assets
(0.38) 
Return On Equity
(0.72) 
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.